Abstract
The well-characterized interaction between the MS2 coat protein and its cognate RNA hairpin was used to evaluate changes in affinity as a result of phosphorodithioate (PS2) replacing phosphate by biolayer interferometry (BLI). A structure-based analysis of the data provides insights into the origins of the enhanced affinity of RNA-protein interactions triggered by the PS2 moiety.
TOC graphic
A single phosphorodithioate in place of a phosphate in a 19mer hairpin-RNA regio-specifically boosts its affinity for MS2 phage coat protein.
Oligoribonucleotides (RNAs) such as RNA aptamers,1–3 siRNAs,4–6 and miRNAs7, 8 show tremendous potential as therapeutics against viral infections, cancer, genetic disorders, and neurological diseases.9, 10 Beyond their therapeutic potential, aptamers are of high value as tools for biological research, such as target validation,11–13 and as biosensors in diagnostics.14 One of the limiting factors in the success of RNA-based therapeutics is the typically rapid degradation of unmodified RNAs in serum and within cells. This problem has been greatly diminished by modifications that render RNAs resistant to the action of cellular nucleases.15 One of the most commonly employed modifications is the replacement of a non-bridging oxygen with sulfur in phosphate linkages to form phosphoromonothioate (PS)-modified RNA.16 However, PS-modified RNAs afford only limited protection against hydrolysis by nucleases16 and the PS modification results in a mixture of diastereomeric RNAs that raises the potential of variable biophysical properties. Stereo-controlled synthesis of P-chiral PS-RNAs represents one possible solution to this problem,17, 18 but another lies in the synthesis of modifications that are achiral at phosphorus such as phosphorodithioate (PS2)-modified RNAs.19
PS2-RNA is a very attractive RNA analog because it closely mimics natural RNA. It has been shown that dinucleoside phosphorodithioates (PS2-dimers) have high nuclease resistance.20 In addition, a hammerhead ribozyme with a single PS2 substitution at the cleavage site maintained activity and cleavage resulted in the expected product.21 Moreover, PS2-dimers have shown great resistance to alkaline degradation when compared to natural RNA derivatives.20 Further, we have demonstrated that the greatly improved gene silencing activities in vitro and in vivo19, 22 as a result of introducing two PS2 modifications at the 3¢-end of sense strand siRNAs were a consequence of the higher affinity of PS2-RNA for Ago2 protein, presumably caused by a hydrophobic effect.23 Recent studies have shown that combined 2′-OMe-PS2 or 2′-F-PS2 substitution experiments with in vitro selected RNA aptamers24, 25 led to either a reduction or increase in binding affinity.26 A destabilizing effect by 2′-modification could be due to altered sterics (2′-OMe vs. 2′-OH), loss of H-bonding (2′-OMe vs. 2′-OH), or arise as a consequence of modifying a residue that adopts a C2′-endo pucker, i.e. shifting the conformational equilibrium to C3′-endo compared to the native ribose (as seen with the 2′-F analog).
The question of how individual PS2 modifications will alter the binding between bacteriophage MS2 coat protein and a 19mer stem-loop RNA (Figure 1A) provided the starting point for the present study. The MS2 system is well suited for three reasons. (1) The X-ray crystal structure of the complex reveals protein-phosphate contacts of a very diverse nature within a small RNA molecule.27 (2) Experiments with PS modification have been completed in this system,28 such that these data can be compared to the effects of PS2 modification obtained here. (3) The MS2 model system entails a relatively short RNA that is ideal for a backbone walk to generate all 18 stem-loop constructs that feature a single PS2 moiety. Substitution of two non-bridging oxygen atoms by sulfur is fairly conservative in terms of the changes in the nucleotide geometry, as revealed by our recent PS2-RNA X-ray crystal structures.23 However, differences between PO2 and PS2 in terms of polarizability, hydrophobicity and other factors are expected to significantly change the contribution of individual amino acid-phosphate contacts to the overall binding affinity upon PS2 substitution in a site-specific fashion.
To evaluate the effect of a PS2 substitution at a given position on the binding affinity, a 5′-biotinylated 19-nucleotide hairpin RNA (Figure 1A)27 and PS2 variants with one phosphate per sequence substituted by a PS2 moiety were synthesized via standard solid phase phosphoramidite chemistry (Supplementary Table 1, ST-1). Kinetic characterization of each PS2 variant by BLI allowed affinity ranking of modified hairpins with respect to the native RNA. Evaluation consisted of using a serial dilution of MS2 protein screened against individual hairpin RNA variants that were immobilized onto streptavidin coated BLI sensors.26, 29 Binding and dissociation rates of native hairpin RNA were determined in parallel to the variants. Supplementary Figure 1 (SF-1) shows the characterization of native RNA and all of its PS2 modified variants. ST-2 shows the calculated KD values and relative KD ratio for each variant relative to the native hairpin RNA. As is evident from ST-2, the effects of single PS2 modifications on binding are variable. Of the 18 PS2-modified RNAs tested, three displayed significantly increased binding affinity (at least 15-fold compared to the corresponding control RNA). PS2 substitutions at the remaining sites either did not affect binding or led to slightly increased/decreased binding affinities (less than 3-fold) (Figure 1B).
The MS2 system was used previously to assess the consequences of single PS substitutions in the hairpin RNA for the tightness of the RNA-coat protein interaction.28 The effect of a single PS substitution on the overall protein binding affinity is relatively small (2- to 5-fold). In contrast, the affinity increases of hairpin variants with P5, P12, or P14 replaced by PS2 were significantly larger (54-, 16- and 71-fold, respectively) (Figure 1B). Unlike in a PS moiety where the negative charge resides on the sulfur, either sulfur atom in PS2 can be neutral or charged, thus rendering the latter more hydrophobic. The more dramatic increases in binding affinity for certain PO2 → PS2 substitutions are consistent with our recent results based on PS2-modified aptamers targeting VEGF or thrombin.26 What are the underlying reasons for affinity increases upon PS2 substitution? The fact that the P-S bond is longer than the P-O bond (by ca. 0.5 Å; 1.98 vs. 1.50 Å, respectively30, 31) cannot be the most important factor in this regard. Instead, the increased hydrophobicity and polarizability of sulfur relative to oxygen (both PO2 and PS2 are negatively charged), potentially in combination with local flexing of the backbone to allow for an optimal fit between PS2 moiety and protein surface,26 may be key contributors to 50- to 100-fold or even more drastic gains in affinity seen for certain PS2 variants. It is crucial that there is room to accommodate the larger PS2 moiety and an already tightly bound PO2 is unlikely to be conducive to affinity gains.
MS2 coat protein forms an icosahedral capsid (homo-180mer) that encloses RNA hairpins (SF-2). Individual hairpins are spread across an antiparallel β-sheet such that each RNA interacts with residues from two adjacent MS2 protein molecules (SF-3). In order to gain insight into the altered regio-specific interactions as a result of PS2 modification that give rise to affinity increases, we inspected crystal structures of MS2 coat-protein RNA complexes [PDB ID codes 1zdh, 1zdi].27 Both complexes contain native RNA, without PS2 modification.
PS2 modification at the P14 phosphate group that is located between loop residues U13 and A14 exerts the most favorable effect on KD among all tested modification sites. Compared to the native RNA hairpin, the PS2-14 modification results in 71-fold improvement of KD, a gain that is primarily based on the increased association rate (ST-2). Inspection of the crystal structure shows that C8-H of A14 and the Nζ groups of K43 (salt bridge) and K61 are in the vicinity of the pro-Rp sulfur (Figure 2A). The Cγ2 ring carbon of Y85 is somewhat farther away (5.8 Å). By contrast, based on the conformation observed in the crystal structure, the pro-Sp sulfur is not in close contact with protein residues or RNA atoms. However, PS-modification studies demonstrated that both RP- and SP-PS modification affect the affinity between RNA and MS2 coat protein.28 A sizable shift of this PS2 moiety along with a rotation could generate favorable electrostatic and hydrophobic interactions with the two lysines (including lysine methylene groups as seen in a PS2-DNA: protein complex32) and C8-H of A14 and the Y45 ring, similar to PS2 contacts with C8-H of G and phenylalanine, respectively, in our crystal structure of the 2′-F-PS2-RNA:thrombin complex.26
PS2-5 near the base of the RNA stem lies in vicinity of the R49, S51 and K57 side chains (Figure 2B). The pro-RP sulfur is positioned somewhat closer to the two basic residues than the pro-SP one, but the latter has the potential to move closer to methylene groups from S51 and K57. SP-PS modification appears to have a small beneficial effect on affinity,28 but is clearly no match for the 54-fold improvement in KD as a consequence of PS2 modification. The analysis here based on the structure of the complex suggests that the PS2 pro-Sp sulfur may be more important in terms of improving hydrophobic interactions. Similar to the situation in the 2′-F-PS2-RNA:thrombin interaction,26 hydrophobic contributions are enhanced by the negative charge of the PS2 moiety that result in electrostatically favorable interactions, i.e. PS2 pro-Rp sulfur with R49/K57.
The pro-RP and pro-SP moieties of PS2-12 feature very different environments (Figure 2C). The nucleobase of U13 stacks onto the Y85 side chain (supposedly seeding the RNA:MS2 interaction27) and the pro-Rp sulfur is situated in close vicinity (van der Waals contacts) of O4 and C5 of U13 as well as Cδ2 and Cε2 (slightly longer distances) of tyrosine. By contrast the pro-SP sulfur is pointing away from protein and RNA and is not engaged in any interaction. This view is confirmed by the results of the PS-interference study that showed that the RP-PS modification improves the affinity whereas SP-PS modification plays a negligible role.28 U13 continues the stack between G10 and A11, but U12 points away and does not engage in stacking. A slight movement of the PS2-12 moiety could lead to a favorable edge-on interaction with Y85 similar to an edge-on interaction between PS2 and phenylalanine seen in the 2′-F-PS2-RNA:thrombin complex.26 The distances in the model for the pro-RP sulfur are 3.94 Å and 3.66 Å (to Cδ2 and Cε2, respectively).
The three phosphates at positions P8, P10 and P11 are engaged in relatively tight interactions that are dominated by electrostatics (P8 and particularly P10, Figure 3). Both OP1 and OP2 of P8 form H-bonds to K61 and in the case of P10, one of the oxygens (pro-SP) forms two H-bonds to R49 and the other is H-bonded to K57. All three interactions by phosphate 10 are rather tight (distances <3.0 Å) and there are no nearby residues that could be used to improve hydrophobic contacts to a PS2 moiety. P11 is wedged between S51, S52 and Q54 (pro-Sp), whereby the distances are rather tight and this observation and the lack of hydrophobic moieties in the vicinity render this phosphate also a suboptimal environment for a PS2 substitution. Indeed, inspection of the affinity data for PS2 variants at these sites (ST-2) demonstrates that the changes are negligible and similar in magnitude to PS2 substitution at P9, a moiety that lacks interactions with protein (Figure 3).
Conversely, P15, P16 and P17 phosphates that map to a stretch of three Cs in the RNA hairpin are not engaged in direct interactions with MS2 coat protein in the crystal (Figure 2D), and yet they lower (PS2-15, 2-fold, ST-2) and increase affinity (2.5-fold, PS2-16, and 2-fold, PS2-17). In the crystal structure, symmetrical MS2 dimers feature two bound RNAs of different orientation and partial occupancy (Figure 2D). However, it is unclear if such a situation exists in solution, where hairpins are supposedly bound to discrete protein dimers, and how PS2-15, -16 and -17 could indirectly affect affinity.
Conclusions
The structure-based analysis of the results of the PS2 walk along the backbone of the RNA hairpin that binds to MS2 coat protein using crystallographic models of complexes provides helpful insights into the observed changes in KD. Taking into account not just the static models of MS2:RNA complexes in crystal structures but considering potential local conformational changes, significant improvements in KD as a result of PS2 modification at three backbone sites can be rationalized by potentially favorable hydrophobic and electrostatic environments of individual PS2 moieties. Hydrophobic interactions might include edge-on contacts between a PS2 sulfur and an aromatic side chain (Figure 2C),26 contacts between PS2 sulfur and methylene groups of lysine (Figure 2A,B; seen in the crystal structure of the PS2-DNA:homeodomain complex32), and contacts between PS2 sulfur and methylene and methyl groups of serine and threonine, respectively (Figure 2). Such interactions would be supplemented by electrostatically favorable contacts between PS2 and lysine and arginine head groups because the PS2 group still carries a negative charge. The higher association rates for the PS2-14 and PS2-5 hairpins (ST-2) might imply that modification there facilitates conformational selection required for complex formation.
Taking into account dynamic aspects to help explain the observed changes in KD as a result of the PS2 backbone walk is justified in the case of the RNA hairpin interacting with MS2 coat protein. This is because close contacts between RNA and protein are limited to two regions: residues A3, C4 and A5 from one strand in the lower stem portion of the hairpin and A11, U12, U13 and A14 in the loop region (SF-2). The nature of these contacts render it entirely possible that PS2 modification could result in more or less subtle conformational changes in the RNA that affect the interactions with the protein (we don’t expect the protein to undergo any conformational changes, consistent with our findings in the structures of PS2-RNA:thrombin complexes26). A structural analysis of a 2′-F-PS2-modified RNA in complex with thrombin demonstrated that the RNA can locally undergo conformational changes (a shift of an individual residue of up to 3 Å and rotation of the PS2 moiety and a neighboring phosphate by more than 90° relative to the orientations of the native phosphates).26 This RNA-induced fit resulted in enhanced hydrophobic contacts – while maintaining favorable Coulombic interactions with lysine and arginine – and calculations provided evidence that the higher polarizability of sulfur compared to oxygen is a contributing factor.26
Combined 2′-F-PS226 or 2′-OMe-PS222 modification of an aptamer26 or siRNA,22 respectively, can boost the affinity for protein targets beyond the improvements with PS2 modification alone. However, in cases where the 2′-OH moiety is engaged in a H-bond with protein, 2´-O-methylation can potentially also destroy the affinity gained by the 3′-PS2 substitution. This is seen with 2´-OMe-3′-PS2 (MS2) modified U13 that displays a KD of 3.77 nM (ST-2: AF151UB) compared with 1.54 nM for PO2 (ST-2: AF147-1), and 0.028 nM for PS2 (ST-2: AF151-12), respectively. Methylation there destroys the H-bond to E63, creates a steric conflict with Y85, and likely destabilizes the C2´-endo sugar pucker of U13 (Figure 2A).
The PS2-mediated affinity gains achieved here for the RNA:MS2 interaction reach almost two orders of magnitude. By comparison, the affinity changes in the siRNA:Ago2, RNA:thrombin and RNA:VEGF complexes were up to 1,000-fold.23, 26 Both anti-thrombin and -VEGF RNA aptamer are more complex than the MS2 RNA harpin. Rather than an induced fit, the latter motif may merely undergo PS2-triggered flexing to promote higher affinity. Perhaps a simple RNA stem-loop motif precludes a 1,000-fold boost in KD in response to a single PS2 moiety. Nevertheless, the observed gains in affinity are impressive and dwarf those seen for duplex DNA that is conformationally more rigid by comparison.
Supplementary Material
Acknowledgments
Funding was provided by NIH (GM108110) and National Natural Science Foundation of China (21372207).
Footnotes
Electronic Supplementary Information (ESI) available: General materials, RNA and modified RNA synthesis methods, Modified RNA sequence information (ST-1), affinity information (ST-2 and SF-1), Structure of the MS2 coat protein-RNA complex (SF-2), and overall view of interactions between MS2 protein and RNA hairpin (SF-3).
Notes and references
- 1.Keefe AD, Pai S, Ellington A. Nat Rev Drug Discov. 2010;9:537–550. doi: 10.1038/nrd3141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Osborne SE, Ellington AD. Chem Rev. 1997;97:349–370. doi: 10.1021/cr960009c. [DOI] [PubMed] [Google Scholar]
- 3.Tuerk C, Gold L. Science. 1990;249:505–510. doi: 10.1126/science.2200121. [DOI] [PubMed] [Google Scholar]
- 4.Pushparaj PN, Aarthi JJ, Manikandan J, Kumar SD. J Den Res. 2008;87:992–1003. doi: 10.1177/154405910808701109. [DOI] [PubMed] [Google Scholar]
- 5.Behlke MA. Mol Ther. 2006;13:644–670. doi: 10.1016/j.ymthe.2006.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Nature. 2001;411:494–498. doi: 10.1038/35078107. [DOI] [PubMed] [Google Scholar]
- 7.Melo SA, Esteller M. Cell Cycle. 2011;10:922–925. doi: 10.4161/cc.10.6.15119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Small EM, Olson EN. Nature. 2011;469:336–342. doi: 10.1038/nature09783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, John M, Kesavan V, Lavine G, Pandey RK, Racie T, Rajeev KG, Rohl I, Toudjarska I, Wang G, Wuschko S, Bumcrot D, Koteliansky V, Limmer S, Manoharan M, Vornlocher HP. Nature. 2004;432:173–178. doi: 10.1038/nature03121. [DOI] [PubMed] [Google Scholar]
- 10.Bouchard PR, Hutabarat RM, Thompson KM. Annu Rev Pharmacol Toxicol. 2010;50:237–257. doi: 10.1146/annurev.pharmtox.010909.105547. [DOI] [PubMed] [Google Scholar]
- 11.Jain KK. Drug Discov Today. 2004;9:307–309. doi: 10.1016/S1359-6446(04)03050-8. [DOI] [PubMed] [Google Scholar]
- 12.Pendergrast PS, Marsh HN, Grate D, Healy JM, Stanton M. J Biomol Tech. 2005;16:224–234. [PMC free article] [PubMed] [Google Scholar]
- 13.Blank M, Blind M. Curr Opin Chem Biol. 2005;9:336–342. doi: 10.1016/j.cbpa.2005.06.011. [DOI] [PubMed] [Google Scholar]
- 14.Mairal T, Ozalp VC, Sanchez P Lozano, Mir M, Katakis I, O’Sullivan CK. Anal Bioanal Chem. 2008;390:989–1007. doi: 10.1007/s00216-007-1346-4. [DOI] [PubMed] [Google Scholar]
- 15.Deleavey GF, Damha MJ. Chem Biol. 2012;19:937–954. doi: 10.1016/j.chembiol.2012.07.011. [DOI] [PubMed] [Google Scholar]
- 16.Burgers PMJ, Eckstein F. Biochemistry. 1979;18:592–596. doi: 10.1021/bi00571a007. [DOI] [PubMed] [Google Scholar]
- 17.Stec WJ, Wilk A. Angew Chem Int Ed Engl. 1994;33:709–722. [Google Scholar]
- 18.Wada T, Fujiwara S, Sato T, Oka N, Saigo K. Nucleic Acids Symp Ser (Oxford) 2004:57–58. doi: 10.1093/nass/48.1.57. [DOI] [PubMed] [Google Scholar]
- 19.Yang X, Sierant M, Janicka M, Peczek L, Martinez C, Hassell T, Li N, Li X, Wang T, Nawrot B. ACS Chem Biol. 2012;7:1214–1220. doi: 10.1021/cb300078e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Petersen KH, Nielsen J. Tet Lett. 1990;31:911–914. [Google Scholar]
- 21.Derrick WB, Greef CH, Caruthers MH, Uhlenbeck OC. Biochemistry. 2000;39:4947–4954. doi: 10.1021/bi000146a. [DOI] [PubMed] [Google Scholar]
- 22.Wu SY, Yang X, Gharpure KM, Hatakeyama H, Egli M, McGuire MH, Nagaraja AS, Miyake TM, Rupaimoole R, Pecot CV, Taylor M, Pradeep S, Sierant M, Rodriguez-Aguayo C, Choi HJ, Previs RA, Armaiz-Pena GN, Huang L, Martinez C, Hassell T, Ivan C, Sehgal V, Singhania R, Han HD, Su C, Kim JH, Dalton HJ, Kovvali C, Keyomarsi K, McMillan NA, Overwijk WW, Liu J, Lee JS, Baggerly KA, Lopez-Berestein G, Ram PT, Nawrot B, Sood AK. Nat Commun. 2014;5:3459. doi: 10.1038/ncomms4459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pallan P, Yang X, Sierant M, Abeydeera N, Hassell T, Martinez C, Janicka M, Nawrot B, Egli M. RSC Adv. 2014;4:64901–64904. [Google Scholar]
- 24.White R, Rusconi C, Scardino E, Wolberg A, Lawson J, Hoffman M, Sullenger B. Mol Ther. 2001;4:567–573. doi: 10.1006/mthe.2001.0495. [DOI] [PubMed] [Google Scholar]
- 25.Burmeister PE, Lewis SD, Silva RF, Preiss JR, Horwitz LR, Pendergrast PS, McCauley TG, Kurz JC, Epstein DM, Wilson C, Keefe AD. Chem Biol. 2005;12:25–33. doi: 10.1016/j.chembiol.2004.10.017. [DOI] [PubMed] [Google Scholar]
- 26.Abeydeera ND, Egli M, Cox N, Mercier K, Conde JN, Pallan PS, Mizurini DM, Sierant M, Hibti FE, Hassell T, Wang T, Liu FW, Liu HM, Martinez C, Sood AK, Lybrand TP, Frydman C, Monteiro RQ, Gomer RH, Nawrot B, Yang X. Nucleic Acids Res. 2016;44:8052–8064. doi: 10.1093/nar/gkw725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Valegard K, Murray JB, Stonehouse NJ, van den Worm S, Stockley PG, Liljas L. J Mol Biol. 1997;270:724–738. doi: 10.1006/jmbi.1997.1144. [DOI] [PubMed] [Google Scholar]
- 28.Dertinger D, Behlen LS, Uhlenbeck OC. Biochemistry. 2000;39:55–63. doi: 10.1021/bi991769v. [DOI] [PubMed] [Google Scholar]
- 29.Lou X, Egli M, Yang X. Curr Protoc Nucleic Acid Chem. 2016;67:7.25.1–7.25.15. doi: 10.1002/cpnc.18. [DOI] [PubMed] [Google Scholar]
- 30.Volk DE, Power TD, Gorenstein DG, Luxon BA. Tet Lett. 2002;43:4443–4447. [Google Scholar]
- 31.Okuniewski A, Becker B. Acta Cryst. 2011;E67:1749–1750. [Google Scholar]
- 32.Zandarashvili L, Nguyen D, Anderson KM, White MA, Gorenstein DG, Iwahara J. Biophys J. 2015;109:1026–1037. doi: 10.1016/j.bpj.2015.07.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.